Spero Therapeutics Profit Margin 2016-2021 | SPRO
Current and historical gross margin, operating margin and net profit margin for Spero Therapeutics (SPRO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Spero Therapeutics net profit margin as of June 30, 2021 is -411.53%.
|Spero Therapeutics Annual Profit Margins
|Spero Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.